TEVA Stock Ownership Activity

TEVA PHARMACEUTICAL-SP ADR 13F holders

2 value investing gurus have made changes to the TEVA PHARMACEUTICAL-SP ADR (TEVA) position according to the gurus' latest SEC quarterly report(s). TEVA has been bought (as a new position) by 1 guru(s), the number of TEVA shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying TEVA now?

According to the latest SEC filing(s) TEVA PHARMACEUTICAL-SP ADR (TEVA) has been bought by Ole Andreas Halvorsen - Viking Global Investors (new buy).

To see more about who is investing in TEVA PHARMACEUTICAL-SP ADR (TEVA), please go to the TEVA ownership page.

2017 Q4 (4 results)
Warren Buffett
buy
+18,875,721
+0.19%
0.19%
Bill Miller
buy
+516,112
+0.42%
0.42%
David Abrams
-8.70%
-1,288,322
-1.20%
8.63%
Francis Chou
-97.03%
-490,000
-4.05%
0.12%
Current price: $17.08 9.85% AVG reported price*: $18.95
2017 Q3 (2 results)
David Abrams
buy
+21,623,886
+14.85%
14.85%
Ronald Muhlenkamp
-99.34%
-105,805
-0.60%
0.00%
Current price: $17.08 1.68% AVG reported price*: $17.37
2017 Q2 (3 results)
Francis Chou
+134.88%
+147,900
+3.03%
2.69%
Ronald Muhlenkamp
-0.13%
-97
-0.00%
0.81%
David Tepper
-100.00%
-2,175,000
-1.04%
0.00%
Current price: $17.08 48.68% AVG reported price*: $33.28
2017 Q1 (3 results)
Francis Chou
buy
+138,675
+2.33%
1.50%
Ronald Muhlenkamp
-55.54%
-128,580
-1.39%
1.07%
David Tepper
-56.96%
-2,878,000
-1.61%
0.00%
Current price: $17.08 46.77% AVG reported price*: $32.09
2016 Q4 (3 results)
David Tepper
buy
+4,168,725
+3.38%
2.79%
Ronald Muhlenkamp
+36.48%
+64,119
+0.78%
2.90%
Ole Andreas Halvorsen
-100.00%
-19,684,219
-4.12%
0.00%
Current price: $17.08 52.88% AVG reported price*: $36.25
2016 Q3 (2 results)
Ronald Muhlenkamp
-0.50%
-885
-0.02%
3.09%
Ole Andreas Halvorsen
-29.03%
-8,052,436
-1.60%
0.00%
Current price: $17.08 62.88% AVG reported price*: $46.01
2016 Q2 (2 results)
Ronald Muhlenkamp
-0.29%
-489
-0.01%
3.39%
Ole Andreas Halvorsen
-15.88%
-5,234,967
-1.12%
5.92%
Current price: $17.08 66.00% AVG reported price*: $50.23
2016 Q1 (2 results)
Ole Andreas Halvorsen
+31.66%
+7,927,847
+1.87%
7.77%
Ronald Muhlenkamp
+0.12%
+205
+0.00%
3.90%
Current price: $17.08 68.08% AVG reported price*: $53.51
2015 Q4 (1 result)
Ole Andreas Halvorsen
+182.26%
+16,171,125
+4.00%
6.20%
Current price: $17.08 73.98% Reported price*: $65.64
2015 Q3 (2 results)
Ole Andreas Halvorsen
buy
+8,872,650
+1.92%
1.92%
Ronald Muhlenkamp
+0.02%
+40
+0.00%
3.07%
Current price: $17.08 69.75% AVG reported price*: $56.46
2015 Q2 (2 results)
Ronald Muhlenkamp
+0.12%
+205
+0.00%
2.36%
Ole Andreas Halvorsen
-100.00%
-228,600
-0.05%
0.00%
Current price: $17.08 71.10% AVG reported price*: $59.10
2015 Q1 (2 results)
Ole Andreas Halvorsen
buy
+228,600
+0.06%
0.00%
Ronald Muhlenkamp
+0.18%
+266
+0.00%
1.91%
Current price: $17.08 72.58% AVG reported price*: $62.30
2014 Q4 (1 result)
Ronald Muhlenkamp
-0.27%
-470
-0.01%
2.05%
Current price: $17.08 70.30% Reported price*: $57.51
2014 Q2 (1 result)
Ronald Muhlenkamp
+0.81%
+1,415
+0.01%
1.65%
Current price: $17.08 67.42% Reported price*: $52.42
2014 Q1 (1 result)
Ronald Muhlenkamp
-0.51%
-589
-0.01%
1.08%
Current price: $17.08 67.68% Reported price*: $52.84
2013 Q4 (2 results)
Ronald Muhlenkamp
+3.74%
+6,355
+0.05%
1.25%
Ravenel Boykin Curry IV
-100.00%
-14,783
-0.00%
0.00%
Current price: $17.08 57.39% AVG reported price*: $40.08
2013 Q3 (2 results)
Ronald Muhlenkamp
+0.19%
+269
+0.00%
1.07%
David Abrams
-100.00%
-1,447,116
-7.86%
0.00%
Current price: $17.08 54.79% AVG reported price*: $37.78
2013 Q2 (3 results)
Ronald Muhlenkamp
buy
+104,340
+1.40%
0.86%
Ravenel Boykin Curry IV
buy
+20,832
+0.00%
0.00%
David Abrams
buy
+1,447,116
+5.81%
0.00%
Current price: $17.08 56.43% AVG reported price*: $39.20
38 of 87

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.